Marco Isaac Banda-Lara

Learn More
OBJECTIVE We evaluated the effectiveness of a raltegravir (RAL)-containing regimen plus an optimized background regimen in HIV-1 highly treatment-experienced patients. DESIGN A retrospective cohort, multicentre study was conducted. METHODS Adult (>16 years old) HIV treatment-experience patients starting therapy with a RAL-containing regimen were(More)
  • 1